Western Pacific Wealth Management’s Novo Nordisk NVO Stock Holding History

Western Pacific Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.83K	Hold	80	–	–	﹤0.01%	168
2026 Q1	$2.94K	Hold	80	–	–	﹤0.01%	173
2025 Q4	$4.07K	Hold	80	–	–	﹤0.01%	160
2025 Q3	$4.44K	Hold	80	–	–	﹤0.01%	170
2025 Q2	$5.52K	Hold	80	–	–	0.01%	173
2025 Q1	$5.55K	Hold	80	–	–	0.01%	172
2024 Q4	$6.88K	Hold	80	–	–	0.01%	175
2024 Q3	$9.53K	Hold	80	–	–	0.01%	208
2024 Q2	$11.4K	Hold	80	–	–	0.01%	181
2024 Q1	$10.3K	Hold	80	–	–	0.01%	189
2023 Q4	$8.28K	Hold	80	–	–	0.01%	194
2023 Q3	$7.28K	Hold	80	–	–	0.01%	199
2023 Q2	$6.47K	Buy	80 +24	+43%	+$1.96K	﹤0.01%	206
2023 Q1	$4.46K	Hold	56	–	–	﹤0.01%	235
2022 Q4	$3.79K	Hold	56	–	–	﹤0.01%	238
2022 Q3	$2K	Hold	56	–	–	﹤0.01%	223
2022 Q2	$3K	Hold	56	–	–	﹤0.01%	168
2022 Q1	$3K	Hold	56	–	–	﹤0.01%	193
2021 Q4	$3K	Buy	+56	New	+$3.03K	﹤0.01%	195

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Western Pacific Wealth Management's NVO Position: Q2 2026 in Review

Western Pacific Wealth Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 80 shares worth $3.83K. The position accounts for ﹤0.01% of the portfolio, ranked #168.

Western Pacific Wealth Management first reported a position in NVO in Q4 2021 and has held it in 19 quarters since. The position peaked at $11.4K in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Western Pacific Wealth Management held 80 shares of Novo Nordisk worth $3.83K as of Q2 2026.
Western Pacific Wealth Management left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up ﹤0.01% of Western Pacific Wealth Management's portfolio in Q2 2026, its #168 holding.
Western Pacific Wealth Management first reported a position in Novo Nordisk in Q4 2021 and has held it in 19 quarters since.
Western Pacific Wealth Management's Novo Nordisk position peaked at $11.4K in Q2 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Western Pacific Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.